Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up
TE

TECH

Market Closed

Bio-Techne Corporation

NASDAQHealthcareBiotechnology
US
3.10K employees
CEO: Kim Kelderman
Founded: 1989
$57.94
+$0.00(+NaN%)
Market Cap
9.07B
Beta
1.36
52W Range
N/A
Dividend Yield
0.55%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Bio-Techne trades 39% above a high-confidence fair value of $35.41, indicating potential overvaluation. Monte Carlo analysis shows high downside risk with median valuation well below current price and significant volatility. Strong liquidity contrasts weak profitability and growth, signaling fundamental challenges amid price premium.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore TECH

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

TECH in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms